Disease Agents Articles & Analysis
14 news found
Infectious diseases are disorders caused by organisms — such as bacteria, viruses, or parasites. A vaccine is a specialized biological formulation that triggers the immune system to recognize and activate protective responses against specific disease-causing agents. With the global landscape of infectious diseases ...
AMReady is a very complete consortium of institutions led by Vaxdyn and formed by the Barcelona-based international pharmaceutical manufacturer Laboratorios Reig Jofre and top groups in Immunology and infectious diseases of the National Microbiology Center (CNM) of the Spanish Institutes of Health “Carlos III” (ISCIII) in Madrid (Spain), the Faculty of Veterinary ...
Breakthrough Designation has been granted for the proposed indication of using the NeuroMotor PenTM to support health care providers (HCPs) in differentiating between Parkinsonian and non-Parkinsonian tremors in adult patients who are suspected to have Parkinson’s Disease (PD) but have not been diagnosed by other means. The FDA Breakthrough Device programme is intended to ...
“Enzyme conjugation is a rapidly growing business in medical diagnostics, gene expression analysis, infectious disease detection, and biological warfare agent identification, among other applications. ...
While the advent of these inhibitors has brought significant benefit to patients with cancer, there is still significant unmet need even in disease indications for which these agents are approved. Adenosine has an immune-suppressive effect in tumors, and pre-clinical and early clinical evidence indicates that antagonists of the GPCR family of adenosine receptors ...
FUSION GENOMICS Corporation is a molecular diagnostic company that develops clinical assays using next-generation sequencing technologies to characterize infectious disease agents of clinical and global importance. We are looking to hire a full-time Postdoctoral Fellow to join our team in an exciting and highly dynamic start-up environment. ...
CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Shifa Biomedical Corporation (Shifa), a drug discovery biopharmaceutical company focused on developing novel agents to treat cardiovascular disease and hypercholesteremia, today announced exciting preclinical data involving the company’s pre-clinical candidate, P-21, which interferes with the interaction between ...
Visit our Data Gallery and find new exciting application examples of our Viscover imaging agents such as the investigation of disease-related changes in organ size, in vivo µ-CT of the myocardium, or angiogenesis in ...
EU-OSHA has carried out a project to raise awareness on exposures to biological agents and the related health problems, and the lack of a systematic approach to workplace prevention regarding these risk factors at work. ...
One important role of macrophages is to identify and kill disease agents, such as bacteria, by ingesting or ‘eating’ them. ...
NIEHS As the lead NIH institute focusing on how environmental factors impact human health, NIEHS is working to understand how exposures to environmental agents trigger diseases such as asthma, and how we can prevent, diagnose and treat these diseases. ...
NIEHS As the lead NIH institute focusing on how environmental factors impact human health, NIEHS is working to understand how exposures to environmental agents trigger diseases such as asthma, and how we can prevent, diagnose and treat these diseases. ...
If left undiagnosed and untreated, Chagas disease can result in death. In 2007, national screening of the blood supply for the disease was instituted. ...
Room 251-AToxicogenomic technologies provide tools to understand more completely the mechanisms through which environmental agents initiate and advance disease processes. At this lecture, Dr. Richard Paules, a principal investigator at NIEHS, will discuss how NIEHS has contributed to the development of toxicogenomics and the application of genomic technologies to ...